CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline

6 6 月, 2026

One Min Read

1 Views

原文: https://finance.yahoo.com/sectors/healthcare/articles/crispr-therapeutics-ag-crsp-one-001716894.html

Last Update: 6 6 月, 2026

Written By

Other Articles

Previous

Acquisitions Strengthens Red Cat Holdings Inc. (RCAT) Outlook as one of the Most Shorted Mid Cap Stocks to Buy

Next

Lyft Inc. (LYFT) Stands Out Among Most Shorted Mid-Cap Stocks on Ride-Hailing Momentum

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept